| Literature DB >> 24367700 |
Matthias Zunhammer1, Hanna Eberle2, Peter Eichhammer3, Volker Busch3.
Abstract
OBJECTIVE: The etiology of somatization is incompletely understood, but could be elucidated by models of psychosocial stress. Academic exam stress has effectively been applied as a naturalistic stress model, however its effect on somatization symptoms according to ICD-10 and DSM-IV criteria has not been reported so far. Baseline associations between somatization and personality traits, such as alexithymia, have been studied exhaustively. Nevertheless, it is largely unknown if personality traits have an explanatory value for stress induced somatization.Entities:
Mesh:
Year: 2013 PMID: 24367700 PMCID: PMC3867544 DOI: 10.1371/journal.pone.0084911
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Timeline.
Figure 2Participant flow-chart.
The effects of exam period on measures of somatic symptoms and stress: Descriptive results.
|
|
|
| |
|---|---|---|---|
| n=141 | n=123 | n=118 | |
| Mean±SD | |||
|
| |||
|
| 11.1±8.9 | 18.2±14.5 | 9.7±9.0 |
|
| |||
|
| 33.6±17.5 | 54.0±19.3 | 29.8±18.3 |
|
| 6.6±6.4 | 11.5±7.0 | 5.2±5.4 |
|
| 36.9±8.1 | 42.74±12.3 | 37.1±10.3 |
|
| |||
|
| 45.3±9.7 | 45.9±10.1 | 44.6±10.2 |
Abbreviations: BDI-II: Beck’s Depression Inventory; PSQ-20: Perceived Stress Questionnaire; SOMS-7d: Screening for Somatoform Symptoms 7-day version; STAI-G-X1 state: State-Trait Anxiety Inventory – State Form; TAS-20: Toronto Alexithymia Scale 20-item version.
The effects of exam period on measures of somatic symptoms and stress: Mixed model results.
|
|
| |
|---|---|---|
| df1=4 | β±SEM | |
|
| ||
|
| df2=6, F=18.92, | βExam=8.89±1.06, t=8.42, |
| βpreBL=1.77±0.69, t=2.553, | ||
| βMESyes=2.44±1.11, t=2.20, | ||
| βyesDIS=7.63±3.15, t=2.42, p=.076 | ||
|
| ||
|
| df2=168, F=55.68, | βExam=24.22±1.95, t=12.45, |
| βpreBL=3.98±1.65, t=2.410, | ||
| βyesMES=0.27±2.12, t=0.13, p=.899 | ||
| βyesDIS=15.20±4.25, t=3.58 | ||
|
| df2=63, F=37.02, | βExam=6.60±0.61, t=10.80, |
| βpreBL=1.69±0.50, t=3.17, | ||
| βyesMES=1.04±0.67, t=1.55, p=.124 | ||
| βyesDIS =4.49±1.54, t=2.92, | ||
|
| df2=68, F=10.34, | βExam=5.86±1.19, t=4.92, |
| βpreBL=0.79±0.90, t=0.88, p=.930 | ||
| βyesMES=0.69±1.20, t=0.58, p=.566 | ||
| βyesDIS=6.32±2.40, t=2.63, | ||
|
| ||
|
| df2=377, F=2.71, | βExam=1.80±0.60, t=3.00, |
| βpreBL=0.79±0.56, t=1.41, p=.164 | ||
| βyesMES=0.46±0.93, t=0.49, p=.623 | ||
| βyesDIS=4.14±3.18, t=1.30, p=.359 | ||
All linear mixed models included factors TIME (pre-baseline, exam, post-baseline), MES (yesMES, noMES) and DISORDER (yesDIS, noDIS) and assumed a normal distribution. Degrees of freedom (df2) may vary due to inequal sample sizes and the Satterthwaite approximation used. All analyses were based on 142 subjects contributing 382 data-points. Abbreviations: BDI-II: Beck’s Depression Inventory; GLM: Generalized Linear Model; MES: Medically Explained Symptoms; preBL: pre-baseline; PSQ-20: Perceived Stress Questionnaire; SOMS-7d: Screening for Somatoform Symptoms 7-day version; STAI-G-X1: State-Trait Anxiety Inventory – State Form; TAS-20: Toronto Alexithymia Scale 20-item version; yesDIS: With stable past/chronic disorders; yesMES: Evidence for MES.
Results for somatization items significantly increasing under exam stress.
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|
|
|
| ||||||
| n=141 | n=123 | n=117 | df=2 | ||||
| Mean±SD | % of baseline | Χ2 F, sig | |||||
|
|
| 0.82±0.92 | 1.33±1.11 | 0.71±0.78 | 30.7 | 258.8 | 26.70, **** |
|
|
| 0.65±0.89 | 0.93±0.98 | 0.64±0.79 | 30.7 | 123.1 | 14.91, *** |
|
|
| 0.71±0.86 | 1.24±1.12 | 0.75±0.84 | 29.0 | 474.3 | 26.85, **** |
|
|
| 0.33±0.69 | 0.59±0.88 | 0.34±0.64 | 53.2 | 76.5 | 14.17, *** |
|
|
| 0.45±0.71 | 0.76±0.90 | 0.41±0.66 | 53.8 | 317.8 | 23.64, **** |
|
|
| 0.72±0.94 | 1.24±1.10 | 0.54±0.83 | 79.8 | 199.5 | 43.44, **** |
|
|
| 0.30±0.68 | 0.67±0.97 | 0.22±0.59 | 136.2 | 222.9 | 26.36, **** |
|
|
| 0.22±0.60 | 0.50±0.91 | 0.19±0.53 | 105.3 | 227.9 | 14.24, *** |
|
|
| 0.50±0.85 | 1.03±1.21 | 0.37±0.62 | 66.7 | 487.5 | 29.88, **** |
|
|
| 0.35±0.69 | 0.57±0.83 | 0.23±0.55 | 80.9 | 164.8 | 16.08, *** |
Symptoms were surveyed according to the Screening for Somatoform Symptoms 7-day version (SOMS-7d). Effects of exam period were tested using Friedman’s test (Χ2 F). The alpha-Level was set to p≤.001 to correct for multiple comparisons. Significant results are depicted as **** p≤.0001, *** p≤.001. All post-hoc differences between baselines and exam period were significant as tested with Wilcoxon’s paired rank tests (results not shown). Increases in symptom prevalence are shown in % of valid cases for any severity (score≥1) and severe/very severe only (score≥3) at baseline.
Correlations between somatic symptoms at baseline, somatic symptom increase during an exam period and personality traits.
|
|
|
|
|
| |
|---|---|---|---|---|---|
|
| n=134, τ=.074, p=.212 | ||||
|
|
| n=131, τ=-.050, p=.412 | |||
|
|
|
|
| ||
|
|
| n=134, τ=.074, p=.212 |
|
| |
|
|
| n=134, τ=.066, p=.271 |
|
|
|
All tests were performed using Kendall’s τ-b. Abbreviations: BDI-II: Beck’s Depression Inventory; NEO-FFI: Big Five Personality Inventory, Neuroticism Subscale; SOMS-7d: Screening for Somatoform Symptoms 7 day version; STAI-G-X2: State-Trait Anxiety Inventory – Trait Form; TAS-20: Toronto Alexithymia Scale, 20-item version.
Figure 3The relationship between trait neuroticism, somatic symptoms at baseline and under exam stress.
There was a significant interaction between NEUROTICISM and exam period (β=0.42±0.13(SEM), t=3.30, p=.020), even when accounting for medically explained symptoms and pre-existing disorders. Raw data are shown and simple linear interpolation lines were added for illustrative purposes. To reduce overlap, data points for pre- and post- baseline were shifted by -0.5 and +0.5 points along the x-axis, respectively,